<DOC>
	<DOCNO>NCT00999817</DOCNO>
	<brief_summary>A study study potential effect PF-00299804 inhibition CYP2D6 dextromethorphan .</brief_summary>
	<brief_title>A Pharmacokinetic ( PK ) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Healthy male and/or female non childbearing potential subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Subjects must CYP2D6 extensive metabolizers , ultrarapid metabolizers intermediate metabolizers , predict CYP2D6 genotyping . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen . History regular alcohol consumption exceed 14 drinks/week female 21 drinks/week men ( 1 drink =5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month Screening . Treatment investigational drug within 30 day ( determined local requirement , whichever long ) 5 half life precede first dose study medication . 12 lead ECG demonstrate QTc &gt; 450 msec Screening . If QTc exceed 450 msec , ECG repeat two time average three QTc value use determine subject 's eligibility . Use prescription nonprescription drug dietary supplement within 7 day 5 half life ( whichever longer ) prior first dose study medication . Herbal supplement hormone replacement therapy must discontinue 28 day prior first dose study medication . Depo ProveraÂ® must discontinue least 6 month prior first dose study medication . As exception , acetaminophen/paracetamol may use dos &lt; 1 g/day . Limited use non prescription medication believe affect subject safety overall result study may permit case case basis . Blood donation approximately 1 pint ( 500 mL ) within 56 day prior dose . History sensitivity heparin heparin induce thrombocytopenia . Unwilling unable comply Lifestyle guideline describe protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects</keyword>
</DOC>